Elekta AB (LTS:0O5H) Land And Improvements : kr0 Mil (As of Jan. 2025)

View and export this data going back to 2009. Start your Free Trial

What is Elekta AB Land And Improvements?

Elekta AB's land and improvements for the quarter that ended in Jan. 2025 was kr0 Mil.

Elekta AB Land And Improvements Historical Data

The historical data trend for Elekta AB's Land And Improvements can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Elekta AB Land And Improvements Chart

Elekta AB Annual Data

Trend

Apr15

Apr16

Apr17

Apr18

Apr19

Apr20

Apr21

Apr22

Apr23

Apr24

Land And Improvements

Get a 7-Day Free Trial

Elekta AB Quarterly Data
	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24	Jul24	Oct24	Jan25
Land And Improvements	Get a 7-Day Free Trial															-	-	-	-	-

Elekta AB Land And Improvements Calculation

Land is the surface or crust of the earth, which can be used to support structures, and may be used to grow crops, grass, shrubs, and trees. Land is characterized as having an unlimited life (indefinite). Land improvement is a long-term asset which indicates the cost of the constructed improvements to land, such as driveways, walkways, lighting, and parking lots.

Elekta AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Elekta AB (LTS:0O5H) » Definitions » Land And Improvements

Comparable Companies

Traded in Other Exchanges

EKTAY:USA EKTAF:USA EKTA B:Sweden EKTABs:UK EJXB:Germany

Address

Kungstensgatan 18, Box 7593, Stockholm, SWE, SE-103 93

Website

https://www.elekta.com

Sweden-based Elekta develops, manufactures, and distributes treatment planning systems for neurosurgery and radiotherapy, including stereotactic radiosurgery and brachytherapy. The company has an installed base of more than 7,300 linear accelerators, Gamma Knife and Unity platforms, as well as brachytherapy installations. The company's sales are evenly distributed across geographies, with North and South America accounting for 30%; Europe, the Middle East, and Africa accounting for 36%; and the Asia-Pacific contributing the remainder.

Elekta AB Headlines

No Headlines